A new public-private initiative brings academic and industry researchers from 15 European countries together in a large-scale effort to understand differences…
Articles by Alice Melão
Positive early Phase 1 clinical data in healthy volunteers support Kangpu Biopharmaceuticals’ plan to advance KPG-818 into clinical trials in…
In support of projects in several areas of lupus research, the Lupus Foundation of America has awarded four investigators —…
PredictImmune is planning to expand its pipeline with the development of new strategies to support personalized care for people…
A Phase 2a clinical trial evaluating Resolve Therapeutics‘ investigational treatment RSLV-132 in systemic lupus erythematosus (SLE) has…
The Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) — a tool commonly used to determine disease activity in systemic…
APVO210, an antibody to treat autoimmune and inflammatory diseases such as lupus, has entered a Phase 1 clinical trial to…
The U.S. Patent and Trademark Office (USPTO) is issuing a new patent to Aurinia Pharmaceuticals covering a method of use…
High levels of a protein called HER2 in the urine can help identify children and adolescents with lupus who are…
Aurinia Pharmaceuticals has completed patient enrollment for its Phase 3 trial that will assess the potential of voclosporin…